A capsule-sponge test may help identify patients with Barrett’s esophagus who are at low risk for dysplasia or esophageal ...

Patients with low-grade dysplasia have around a one in 10 chance of developing esophageal cancer, but this risk doubles to one in five for high-grade dysplasia.

In adult patients with nondysplastic Barrett esophagus at last endoscopy, a subsequent capsule-sponge test can assist in identifying those at highest risk of dysplasia or cancer, according to a study ...

The low-grade version is linked with a one in 10 chance of developing esophageal cancer, while the high-grade version increases to a one in five chance. Continued monitoring of the esophagus is vital, ...

As technology continues to evolve, bringing AI, advanced imaging, and novel sampling techniques into routine practice, the ...

Study helps define BE-related risk for dysplasia and esophageal adenocarcinoma. But, protocols not standardized, and data on relevant factors (like hiatal hernia and PPI or NSAID use) not provided.

Indication AVMAPKI FAKZYNJA CO-PACK is indicated for the treatment of adult patients with KRAS -mutated recurrent low-grade serous ovarian cancer (LGSOC) who have received prior systemic therapy.

In Barrett’s esophagus, acid reflux damages throat cells in a way that can transform them into a pre-cancerous state known as dysplasia, researchers said.

Oesophageal cancer articles from across Nature Portfolio Oesophageal cancer is a malignancy of the oesophagus or food pipe . It is a rare malignancy. Nearly all oesophageal cancer are squamous ...